Matches in Wikidata for { <http://www.wikidata.org/entity/Q92169110> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q92169110 description "article scientifique publié en 2019" @default.
- Q92169110 description "artículu científicu espublizáu n'avientu de 2019" @default.
- Q92169110 description "scientific article published on 19 December 2019" @default.
- Q92169110 description "wetenschappelijk artikel" @default.
- Q92169110 description "наукова стаття, опублікована 19 грудня 2019" @default.
- Q92169110 name "Development and validation of a Level A in-vitro in-vivo correlation for tofacitinib modified-release tablets using extrudable core system osmotic delivery technology" @default.
- Q92169110 name "Development and validation of a Level A in-vitro in-vivo correlation for tofacitinib modified-release tablets using extrudable core system osmotic delivery technology" @default.
- Q92169110 type Item @default.
- Q92169110 label "Development and validation of a Level A in-vitro in-vivo correlation for tofacitinib modified-release tablets using extrudable core system osmotic delivery technology" @default.
- Q92169110 label "Development and validation of a Level A in-vitro in-vivo correlation for tofacitinib modified-release tablets using extrudable core system osmotic delivery technology" @default.
- Q92169110 prefLabel "Development and validation of a Level A in-vitro in-vivo correlation for tofacitinib modified-release tablets using extrudable core system osmotic delivery technology" @default.
- Q92169110 prefLabel "Development and validation of a Level A in-vitro in-vivo correlation for tofacitinib modified-release tablets using extrudable core system osmotic delivery technology" @default.
- Q92169110 P1433 Q92169110-1700B431-B08E-44D6-A62F-26DE4EA7BF9F @default.
- Q92169110 P1476 Q92169110-DD70337B-6A02-4A53-B9B2-F07EB299B678 @default.
- Q92169110 P2093 Q92169110-33BB1BBD-8D27-46FE-9612-F9259D5CCDF7 @default.
- Q92169110 P2093 Q92169110-43B62F15-9F05-4FE4-BA22-35B73855E9B2 @default.
- Q92169110 P2093 Q92169110-4657C96D-ABA0-4A71-94CA-228877017860 @default.
- Q92169110 P2093 Q92169110-51A40888-644C-46F1-9DDB-0A76D6200B9A @default.
- Q92169110 P2093 Q92169110-5498D013-6425-4D66-B162-D22FF5444D2D @default.
- Q92169110 P2093 Q92169110-577A7ACC-BF2B-4268-9324-D8E5766BAADB @default.
- Q92169110 P2093 Q92169110-A5084317-5AE7-4770-B37A-D18F2FD48FF5 @default.
- Q92169110 P2093 Q92169110-E9B9FE94-503A-4632-8920-B9EAB8B70E7C @default.
- Q92169110 P2093 Q92169110-FCAC4BBA-5479-44CE-8F7F-CAA30C93DE44 @default.
- Q92169110 P304 Q92169110-EC2FFCBE-9A50-4109-84E4-DC11F1F21E60 @default.
- Q92169110 P31 Q92169110-D85424A8-CF3B-4BC0-BD12-B4A19233243B @default.
- Q92169110 P356 Q92169110-4E90A3B9-D8D4-493F-928D-9611863D0DFA @default.
- Q92169110 P478 Q92169110-21E96585-B870-41F1-A4D2-E8822699B7FB @default.
- Q92169110 P577 Q92169110-FD8A7F05-2ACD-4953-B2A2-A69BA1AA1AD4 @default.
- Q92169110 P698 Q92169110-A5A52562-B641-46E7-9208-6BFA6A016B7A @default.
- Q92169110 P356 J.EJPS.2019.105200 @default.
- Q92169110 P698 31863865 @default.
- Q92169110 P1433 Q5412738 @default.
- Q92169110 P1476 "Development and validation of a Level A in-vitro in-vivo correlation for tofacitinib modified-release tablets using extrudable core system osmotic delivery technology" @default.
- Q92169110 P2093 "Andrew Blanchard" @default.
- Q92169110 P2093 "Christine Alvey" @default.
- Q92169110 P2093 "Joseph Kushner" @default.
- Q92169110 P2093 "Manisha Lamba" @default.
- Q92169110 P2093 "Mary Anne Nemeth" @default.
- Q92169110 P2093 "Raymond Chen" @default.
- Q92169110 P2093 "Ronnie Wang" @default.
- Q92169110 P2093 "Thomas Stock" @default.
- Q92169110 P2093 "Vincent DeMatteo" @default.
- Q92169110 P304 "105200" @default.
- Q92169110 P31 Q13442814 @default.
- Q92169110 P356 "10.1016/J.EJPS.2019.105200" @default.
- Q92169110 P478 "147" @default.
- Q92169110 P577 "2019-12-19T00:00:00Z" @default.
- Q92169110 P698 "31863865" @default.